Hap Trading, LLC Exact Sciences Corp Call Options Transaction History

Hap Trading, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 11, 2023	BUY	$62.68 - $95.05 $670,676 - $1.02 Million	10,700 New	10,700 $1 Million
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $710,190 - $1.24 Million	23,400 Added 30.27%	100,700 $39,000
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $2.47 Million - $3.82 Million	77,300 New	77,300 $13,000
Q2 2021 Aug 11, 2021	SELL	$93.66 - $139.27 $131,124 - $194,978	-1,400 Reduced 11.2%	11,100 $63,000
Q4 2020 Feb 16, 2021	BUY	$99.61 - $142.12 $1.25 Million - $1.78 Million	12,500 New	12,500 $238,000
Q1 2020 May 08, 2020	SELL	$37.9 - $104.44 $2.15 Million - $5.92 Million	-56,700 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$77.66 - $99.74 $2.77 Million - $3.56 Million	-35,700 Reduced 38.64%	56,700 $57,000
Q3 2019 Nov 12, 2019	BUY	$90.37 - $122.49 $6.82 Million - $9.25 Million	75,500 Added 446.75%	92,400 $111,000
Q3 2018 Nov 09, 2018	BUY	$48.29 - $80.6 $333,201 - $556,140	6,900 Added 69.0%	16,900 $264,000
Q2 2018 Aug 13, 2018	BUY	$37.84 - $69.96 $378,400 - $699,599	10,000 New	10,000 $35,000
Q4 2017 Feb 09, 2018	SELL	$46.49 - $60.51 $804,277 - $1.05 Million	-17,300 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$37.05 - $47.12 $640,965 - $815,176	17,300	17,300 $347,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.